|
|
Suppliers for
Levomilnacipran hydrochloride
|
Properties | CAS |
175131-60-9 | Formula |
C15H23ClN2O |
|
|
4 Registered suppliers
Description : Levomilnacipran (brand name Fetzima) is an antidepressant approved for the treatment of major depressive disorder in the United States. It was developed by Forest Laboratories and Pierre Fabre Group, and was approved by the Food and Drug Administration in July 2013. Levomilnacipran is the levo-enantiomer of milnacipran, and has similar effects and pharmacology, acting as a serotonin-norepinephrine reuptake inhibitor (SNRI). - Molecular Weight :282.81
- Purity :98%
Molecular Formula : C15H23ClN2O Canonical SMILES : CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2.Cl InChI : InChI=1S/C15H22N2O.ClH/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12;/h5-9,13H,3-4,10-11,16H2,1-2H3;1H/t13-,15+;/m0./s1 InChIKey : XNCDYJFPRPDERF-NQQJLSKUSA-N Application : Antidepressive Agents Synonyms : (1S,2R)-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide Hydrochloride; cis-(+)-Milnacipran Hydrochloride; (1S,2R)-Milnacipran Hydrochloride; (1S-cis)-Milnacipran Hydrochloride
More details are to be found here
|
|
|
Privileged suppliers
Last update 2024-05-26
|